Active Ingredient(s): Ziv aflibercept
FDA Approved: * August 3, 2012
Pharm Company: * SANOFI AVENTIS US
Category: Cancer

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Zaltrap 100 mg/4ml Intravenous Solution, Concentrate
NDC: 0024-5840
Sanofi-aventis U.S. LLC
Zaltrap 200 mg/8ml Intravenous Solution, Concentrate
NDC: 0024-5841
Sanofi-aventis U.S. LLC

Popular Topics

Zaltrap - help

My husband has just started on Zaltrap. Is there anyone else that is on this drug? (So very little information out there...


Hi Does anyone know the CPT code for Zaltrap?...